Geometric analysis of loco-regional recurrences in relation to pre-treatment hypoxia in patients with head and neck cancer

References

• Nordsmark M, Bentzen SM, Rudat V, et al. Prognostic value of tumor oxygenation in 397 head and neck tumors after primary radiation therapy. An international multi-center study. Radiother Oncol. 2005;77:18–24.
   PubMed Web of Science ®Google Scholar
• Zips D, Zophel K, Abolmaali N, et al. Exploratory prospective trial of hypoxia-specific PET imaging during radiochemotherapy in patients with locally advanced head-and-neck cancer. Radiother Oncol. 2012;105:21–28.
   PubMed Web of Science ®Google Scholar
• Linge A, Löck S, Krenn C, et al. Independent validation of the prognostic value of cancer stem cell marker expression and hypoxia-induced gene expression for patients with locally advanced HNSCC after postoperative radiotherapy. Clin Transl Radiat Oncol. 2016;1:19–26.
   PubMedGoogle Scholar
• Linge A, Lo ck S, Gudziol V, et al. Low cancer stem cell marker expression and low hypoxia identify good prognosis subgroups in HPV(-) HNSCC after postoperative radiochemotherapy: a multicenter study of the DKTK-ROG. Clin Cancer Res. 2016;22:2639–2649.
   PubMed Web of Science ®Google Scholar
• Thorwarth D, Eschmann SM, Scheiderbauer J, et al. Kinetic analysis of dynamic 18F-fluoromisonidazole PET correlates with radiation treatment outcome in head-and-neck cancer. BMC Cancer. 2005;5:152–160.
   PubMed Web of Science ®Google Scholar
• Thorwarth D, Eschmann S-M, Paulsen F, et al. A model of reoxygenation dynamics of head-and-neck tumors based on serial 18F-fluoromisonidazole positron emission tomography investigations. Int J Radiat Oncol. 2007;68:515–521.
   PubMed Web of Science ®Google Scholar
• Pignon J-P, Maître A. l, Maillard E, et al. Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients. Radiother Oncol. 2009;92:4–14.
   PubMed Web of Science ®Google Scholar
• Budach V, Stromberger C, Poettgen C, et al. Hyperfractionated Accelerated Radiation Therapy (HART) of 70.6 Gy with concurrent 5-FU/Mitomycin C is superior to HART of 77.6 Gy alone in locally advanced head and neck cancer: long-term results of the ARO 95-06 randomized phase III trial. Int J Radiat Oncol. 2015;91:916–924.
   PubMed Web of Science ®Google Scholar
• Horsman MR, Mortensen LS, Petersen JB, et al. Imaging hypoxia to improve radiotherapy outcome. Nat Rev Clin Oncol. 2012;9:674–687.
   PubMed Web of Science ®Google Scholar
• Dirix P, Vandecaveye V, De Keyzer F, et al. Dose painting in radiotherapy for head and neck squamous cell carcinoma: value of repeated functional imaging with (18)F-FDG PET, (18)F-fluoromisonidazole PET, diffusion-weighted MRI, and dynamic contrast-enhanced MRI. J Nucl Med. 2009;50:1020–1027.
   PubMed Web of Science ®Google Scholar
• Mortensen LS, Johansen J, Kallehauge J, et al. FAZA PET/CT hypoxia imaging in patients with squamous cell carcinoma of the head and neck treated with radiotherapy: results from the DAHANCA 24 trial. Radiother Oncol. 2012;105:14–20.
   PubMed Web of Science ®Google Scholar
• Welz S, Mönnich D, Pfannenberg C, et al. Prognostic value of dynamic hypoxia PET in head and neck cancer: results from a planned interim analysis of a randomized phase II hypoxia-image guided dose escalation trial. Radiother Oncol. 2017; DOI: 10.1016/j.radonc.2017.04.004.
   PubMed Web of Science ®Google Scholar
• Lee N, Schoder H, Beattie B, et al. Strategy of using intratreatment hypoxia imaging to selectively and safely guide radiation dose de-escalation concurrent with chemotherapy for locoregionally advanced human papillomavirus-related oropharyngeal carcinoma. Radiat Oncol Biol. 2016;96:9–17.
   PubMed Web of Science ®Google Scholar
• Toma-Dasu I, Uhrdin J, Antonovic L, et al. Dose prescription and treatment planning based on FMISO-PET hypoxia. Acta Oncol. 2012;51:222–230.
   PubMed Web of Science ®Google Scholar
• Thorwarth D, Eschmann S-M, Paulsen F, et al. Hypoxia dose painting by numbers: a planning study. Int J Radiat Oncol Biol Phys. 2007;68:291–300.
   PubMed Web of Science ®Google Scholar
• Zschaeck S, Haase R, Abolmaali N, et al. Spatial distribution of FMISO in head and neck squamous cell carcinomas during radio-chemotherapy and its correlation to pattern of failure. Acta Oncol. 2015;54:1355–1363.
   PubMed Web of Science ®Google Scholar
• Bittner M, Wiedenmann N, Bucher S, et al. Exploratory geographical analysis of hypoxic subvolumes using 18F-MISO-PET imaging in patients with head and neck cancer in the course of primary chemoradiotherapy. Radiother Oncol. 2013;108:511–516.
   PubMed Web of Science ®Google Scholar
• Okamoto S, Shiga T, Yasuda K, et al. High reproducibility of tumor hypoxia evaluated by 18F-fluoromisonidazole PET for head and neck cancer. J Nucl Med. 2013;54:201–208.
   PubMed Web of Science ®Google Scholar
• Yaromina A, Krause M, Thames H, et al. Pre-treatment number of clonogenic cells and their radiosensitivity are major determinants of local tumour control after fractionated irradiation. Radiother Oncol. 2007;83:304–310.
   PubMed Web of Science ®Google Scholar
• Mönnich D, Welz S, Thorwarth D, et al. Robustness of quantitative hypoxia PET image analysis for predicting local tumor control. Acta Oncol. 2015;54:1364–1369.
   PubMed Web of Science ®Google Scholar
• Due AK, Vogelius IR, Aznar MC, et al. Methods for estimating the site of origin of locoregional recurrence in head and neck squamous cell carcinoma. Strahlenther Onkol. 2012;188:671–676.
   PubMed Web of Science ®Google Scholar